Recherche
-
Untreated patients with multiple sclerosis: a study of French expert centers
(European Journal of Neurology. vol. 28, n° 6, pp. 2026-2036, 2021-06)Article de revueLibre accès -
A Baldwin interpretation of adult hippocampal neurogenesis: from functional relevance to physiopathology
(Molecular Psychiatry. vol. 27, n° 1, pp. 383-402, 2022-01)Article de revueLibre accès -
Do isolated cognitive relapses exist? Commentary
(Multiple Sclerosis Journal. vol. 27, n° 10, pp. 1489-1490, 2021-09)Article de revueLibre accès -
Breathing-driven prefrontal oscillations regulate maintenance of conditioned-fear evoked freezing independently of initiation
(Nature Communications. vol. 12, n° 1, 2021-05-10)Article de revueLibre accès -
Central amygdala micro-circuits mediate fear extinction
(Nature Communications. vol. 12, n° 1, 2021-07-06)Article de revueLibre accès -
Comparative effectiveness of dimethyl fumarate in multiple sclerosis
(British Journal of Clinical Pharmacology, 2021-03)Article de revueLibre accès -
Gipc1 has a dual role in Vangl2 trafficking and hair bundle integrity in the inner ear
(Development (Cambridge, England). vol. 139, n° 20, pp. 3775-3785, 2012-10-15)Article de revueLibre accès -
Primary cilium migration depends on G-protein signalling control of subapical cytoskeleton
(Nature Cell Biology. vol. 15, n° 9, pp. 1107-1115, 2013-09)Article de revue -
Special issue editorial: Cannabinoid signalling in the brain: New vistas.
(European Journal of Neuroscience. vol. 55, n° 4, pp. 903-908, 2022-02-01)Article de revueLibre accès -
PAI-1 protein is a key molecular effector in the transition from normal to PTSD-like fear memory
(Molecular Psychiatry. vol. 26, n° 9, pp. 4968-4981, 2021-09)Article de revueLibre accès